Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
9,161,514
-
Share change
-
-84,161
-
Total reported value
-
$70,265,000
-
Put/Call ratio
-
70%
-
Price per share
-
$7.67
-
Number of holders
-
48
-
Value change
-
+$215,822
-
Number of buys
-
20
-
Number of sells
-
20
Institutional Holders of TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) as of Q4 2015
As of 31 Dec 2015,
TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,161,514 shares.
The largest 10 holders included
KINGDON CAPITAL MANAGEMENT, L.L.C., DEERFIELD MANAGEMENT CO, MILLENNIUM MANAGEMENT LLC, Broadfin Capital, LLC, Opaleye Management Inc., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, Ghost Tree Capital, LLC, Lombard Odier Asset Management (USA) Corp, and venBio Select Advisor LLC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.